Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 198

1.

Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.

Wani S, Falk G, Hall M, Gaddam S, Wang A, Gupta N, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Reddymasu S, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Lieberman DA, Sampliner RE, Sharma P.

Clin Gastroenterol Hepatol. 2011 Mar;9(3):220-7; quiz e26. doi: 10.1016/j.cgh.2010.11.008. Epub 2010 Nov 27.

PMID:
21115133
[PubMed - indexed for MEDLINE]
2.

Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.

Anaparthy R, Gaddam S, Kanakadandi V, Alsop BR, Gupta N, Higbee AD, Wani SB, Singh M, Rastogi A, Bansal A, Cash BD, Young PE, Lieberman DA, Falk GW, Vargo JJ, Thota P, Sampliner RE, Sharma P.

Clin Gastroenterol Hepatol. 2013 Nov;11(11):1430-6. doi: 10.1016/j.cgh.2013.05.007. Epub 2013 May 22.

PMID:
23707463
[PubMed - indexed for MEDLINE]
3.

Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.

Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE.

Clin Gastroenterol Hepatol. 2006 May;4(5):566-72. Epub 2006 Apr 17.

PMID:
16630761
[PubMed - indexed for MEDLINE]
4.

Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study.

Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, van Vuuren AJ, Bode WA, van der Valk H, Ouwendijk RJ, Giard R, Lesterhuis W, Heinhuis R, Klinkenberg EC, Meijer GA, ter Borg F, Arends JW, Kolkman JJ, van Baarlen J, de Vries RA, Mulder AH, van Tilburg AJ, Offerhaus GJ, ten Kate FJ, Kusters JG, Kuipers EJ, Siersema PD.

Am J Gastroenterol. 2011 Jul;106(7):1231-8. doi: 10.1038/ajg.2011.153. Epub 2011 May 17.

PMID:
21577245
[PubMed - indexed for MEDLINE]
5.

Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.

Gaddam S, Singh M, Balasubramanian G, Thota P, Gupta N, Wani S, Higbee AD, Mathur SC, Horwhat JD, Rastogi A, Young PE, Cash BD, Bansal A, Vargo JJ, Falk GW, Lieberman DA, Sampliner RE, Sharma P.

Gastroenterology. 2013 Sep;145(3):548-53.e1. doi: 10.1053/j.gastro.2013.05.040. Epub 2013 May 25.

PMID:
23714382
[PubMed - indexed for MEDLINE]
6.

Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study.

Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, Schipper ME, Casparie MK, van Baal JW, Siersema PD.

Am J Gastroenterol. 2012 Apr;107(4):534-42. doi: 10.1038/ajg.2011.459. Epub 2012 Jan 24.

PMID:
22270082
[PubMed - indexed for MEDLINE]
7.

Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.

Wani S, Falk GW, Post J, Yerian L, Hall M, Wang A, Gupta N, Gaddam S, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Goldblum J, Lieberman DA, Sampliner RE, Sharma P.

Gastroenterology. 2011 Oct;141(4):1179-86, 1186.e1. doi: 10.1053/j.gastro.2011.06.055. Epub 2011 Jun 30.

PMID:
21723218
[PubMed - indexed for MEDLINE]
8.

Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.

Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE.

Am J Gastroenterol. 1997 Nov;92(11):2012-6.

PMID:
9362182
[PubMed - indexed for MEDLINE]
9.

Surveillance in Barrett's esophagus: an audit of practice.

Ajumobi A, Bahjri K, Jackson C, Griffin R.

Dig Dis Sci. 2010 Jun;55(6):1615-21. doi: 10.1007/s10620-009-0917-y. Epub 2009 Aug 11.

PMID:
19669878
[PubMed - indexed for MEDLINE]
10.
11.

Incidence of adenocarcinoma among patients with Barrett's esophagus.

Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P.

N Engl J Med. 2011 Oct 13;365(15):1375-83. doi: 10.1056/NEJMoa1103042.

PMID:
21995385
[PubMed - indexed for MEDLINE]
Free Article
12.

The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.

Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR.

Am J Gastroenterol. 2000 Dec;95(12):3383-7.

PMID:
11151865
[PubMed - indexed for MEDLINE]
13.

Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years.

Hage M, Siersema PD, van Dekken H, Steyerberg EW, Dees J, Kuipers EJ.

Scand J Gastroenterol. 2004 Dec;39(12):1175-9.

PMID:
15742992
[PubMed - indexed for MEDLINE]
14.

Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.

Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL.

Am J Gastroenterol. 2005 Apr;100(4):775-83.

PMID:
15784018
[PubMed - indexed for MEDLINE]
15.

Long-term follow-up of Barrett's high-grade dysplasia.

Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A.

Am J Gastroenterol. 2000 Aug;95(8):1888-93.

PMID:
10950031
[PubMed - indexed for MEDLINE]
16.

Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.

Conio M, Blanchi S, Lapertosa G, Ferraris R, Sablich R, Marchi S, D'Onofrio V, Lacchin T, Iaquinto G, Missale G, Ravelli P, Cestari R, Benedetti G, Macrì G, Fiocca R, Munizzi F, Filiberti R.

Am J Gastroenterol. 2003 Sep;98(9):1931-9.

PMID:
14499768
[PubMed - indexed for MEDLINE]
17.

Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis.

Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P.

Gastrointest Endosc. 2008 Mar;67(3):394-8. Epub 2007 Nov 28. Review.

PMID:
18045592
[PubMed - indexed for MEDLINE]
18.

The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.

Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L.

Am J Epidemiol. 2008 Aug 1;168(3):237-49. doi: 10.1093/aje/kwn121. Epub 2008 Jun 12. Review.

PMID:
18550563
[PubMed - indexed for MEDLINE]
Free Article
19.

Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.

Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ.

Am J Gastroenterol. 2009 Nov;104(11):2673-80. doi: 10.1038/ajg.2009.437. Epub 2009 Jul 28.

PMID:
19638963
[PubMed - indexed for MEDLINE]
20.

The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.

O'Connor JB, Falk GW, Richter JE.

Am J Gastroenterol. 1999 Aug;94(8):2037-42.

PMID:
10445525
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk